secwatch.observer — SEC 8-K summary
======================================

Issuer:     MEDIFAST INC (MED)
CIK:        0000910329
Form:       8-K
Filed at:   2022-06-01T23:59:59+00:00
Accession:  0001628280-22-015819
Event type: other_material
Sentiment:  positive
Materiality: 0.70
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Medifast launches $100M accelerated share repurchase program
------------------------------------------------------------

- Entered ASR with JPMorgan to repurchase $100M of common stock.
- Initial delivery of ~480,000 shares; final settlement expected in Q3 2022.
- Repurchase represents ~600,000 shares at May 31 close, about 5% of fully diluted stock.
- Funded through available cash and borrowings under existing credit facility.
- Approximately 1.4M shares remain available under current repurchase authorization.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/910329/000162828022015819/0001628280-22-015819-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/910329/000162828022015819/med-20220601.htm
  HTML page:      https://secwatch.observer/filing/0001628280-22-015819

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer